TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
There is provided a compound of the formula (I') : wherein X is a nitrogen or CRx, Rx is a hydrogen, etc., R1 is an optionally substituted hydrocarbon group, etc., R2 is an optionally substituted hydrocarbon group, etc., ring A is 5- to -8-membered heterocyclic ring, etc., and each of Y1,. Y2 a...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
10.08.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | There is provided a compound of the formula (I') : wherein X is a nitrogen or CRx, Rx is a hydrogen, etc., R1 is an optionally substituted hydrocarbon group, etc., R2 is an optionally substituted hydrocarbon group, etc., ring A is 5- to -8-membered heterocyclic ring, etc., and each of Y1,. Y2 and Y3 is an optionally substituted carbon or a nitrogen, etc.; or 'a salt thereof or a prodrug thereof., which have CRF receptor antagonistic activity and use thereof.
Se proporciona un compuesto de la fórmula (I'): en donde X es un nitrógeno o CRx, Rx es un hidrógeno, etc., R1 es un grupo de hidrocarburo opcionalmente substituido etc., R2 es un grupo de hidrocarburo opcionalmente substituido, etc., el anillo A es un anillo heterocíclico de 5- a -8-miembros etc., y cada uno de Y1,. Y2 e Y3 es un carbono opcionalmente substituido o un nitrógeno, etc.; o una sal del mismo o un profármaco del mismo, que tiene actividad antagonista del receptor CRF y proporciona también el uso del mismo. |
---|---|
AbstractList | There is provided a compound of the formula (I') : wherein X is a nitrogen or CRx, Rx is a hydrogen, etc., R1 is an optionally substituted hydrocarbon group, etc., R2 is an optionally substituted hydrocarbon group, etc., ring A is 5- to -8-membered heterocyclic ring, etc., and each of Y1,. Y2 and Y3 is an optionally substituted carbon or a nitrogen, etc.; or 'a salt thereof or a prodrug thereof., which have CRF receptor antagonistic activity and use thereof.
Se proporciona un compuesto de la fórmula (I'): en donde X es un nitrógeno o CRx, Rx es un hidrógeno, etc., R1 es un grupo de hidrocarburo opcionalmente substituido etc., R2 es un grupo de hidrocarburo opcionalmente substituido, etc., el anillo A es un anillo heterocíclico de 5- a -8-miembros etc., y cada uno de Y1,. Y2 e Y3 es un carbono opcionalmente substituido o un nitrógeno, etc.; o una sal del mismo o un profármaco del mismo, que tiene actividad antagonista del receptor CRF y proporciona también el uso del mismo. |
Author | TAKAFUMI TAKAI MICHIYO MOCHIZUKI KAZUYUKI TOKUMARU YASUTAKA HOASHI TAKUTO KOJIMA KATSUMI KOBAYASHI KAZUYOSHI ASO |
Author_xml | – fullname: TAKAFUMI TAKAI – fullname: KATSUMI KOBAYASHI – fullname: YASUTAKA HOASHI – fullname: KAZUYOSHI ASO – fullname: MICHIYO MOCHIZUKI – fullname: KAZUYUKI TOKUMARU – fullname: TAKUTO KOJIMA |
BookMark | eNqNjL0OgjAUhRl08O8dGneSKouON6XQm0BL2guRiRBTJwMkuPvqlugDOJ2c7_xso9UwDn4TvcmiaEWBgglTVqbWqWMKGtR5AJZQGLKmQh1bWUhwC89AkLEMNEFuNLpQYgFhg9QGmrJKgS1ByDokUHyPHRIa7YIJM9TLDylZ7qP1o3_O_vDTXXTMJAkV-2ns_Dz1dz_4V1fezvzEOb_w5ArJX6UPyYo_Eg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPUESTOS TRICICLICOS QUE TIENEN ACTIVIDAD ANTAGONISTA DE FACTOR DE LIBERACION DE CORTICOTROPINA Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS MISMOS. |
ExternalDocumentID | MX2010008039A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX2010008039A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:53:12 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX2010008039A3 |
Notes | Application Number: MX20100008039 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100810&DB=EPODOC&CC=MX&NR=2010008039A |
ParticipantIDs | epo_espacenet_MX2010008039A |
PublicationCentury | 2000 |
PublicationDate | 20100810 |
PublicationDateYYYYMMDD | 2010-08-10 |
PublicationDate_xml | – month: 08 year: 2010 text: 20100810 day: 10 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
RelatedCompanies_xml | – name: TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Score | 2.655162 |
Snippet | There is provided a compound of the formula (I') : wherein X is a nitrogen or CRx, Rx is a hydrogen, etc., R1 is an optionally substituted hydrocarbon group,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | TRICYCLIC COMPOUNDS HAVING CORTICOTROPIN-RELEASING FACTOR ANTAGONISTIC ACTIVITY AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100810&DB=EPODOC&locale=&CC=MX&NR=2010008039A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9zivqmU1GnUkT6Vqxr2s6HIVnarpX1gzYb3ZM0bQcibMNVfPRf99Jtuqe9JZfk4AKXu8vlfkHooZNrhdo1cwVcf13BRgcrnPNS6RbY0Kf5tMtrdH0_MNwRfk31tIE-NrUwNU7odw2OCBqVg75X9Xm9-L_Esuq3lctH_g6k-YvDepa8jo4FUs2TKlv9nh2FVkhlSnt-Kgfxagy8I-2Z7KF94UcLoH173BdlKYttm-KcoIMI2M2qU9Qoly10RDdfr7XQob_OeENzrXzLM_TDYo9O6NCjEg39KBwFViK5ZOwFAyDEzIPwPA4hTFdie2iTRNAdQlkYSyRgZBAGXgKTJPFuZOyxCVAtKXJJ7BNqj5gARlgxTry6thg6sMwLBB_m2v45undsRl0FJHn727c3P92SWrtAzdl8Vl4iyTCnZqbyjsm1DGdY47gw1bwwTFPn2MjKK9Teweh652gbHa_y6wI09gY1q8-v8hbMdsXv6u3-BcxQkro |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8QjfimqFHxYzFmb4uTfeEDMaXbWHVf2QqBJ7JuIzEmQGTGR_91bwOUJ97au_aSNrneXa_3K0IP7VTJ5I6RSuD6a5Kqt1WJc55LnUzVtWk67fAKXd_zdWegvo60UQ19bGphKpzQ7wocETQqBX0vqvN68X-JZVZvK5eP_B1I8xebdU1xHR2XSDVPsmj2ulYYmAERCel6I9GPVjzwjpRnvIf2DYgJS6B9a9gry1IW2zbFPkYHIYibFSeoli-bqEE2X6810aG3znhDc618y1P0wyJKxsSlRCCBFwYD34wFBw-p3wdCxCiE51EAYboUWa6F45JuY8KCSMA-w_3ApzEMEsp3I0PKxkA1hdDBkYeJNWAlMMJKcEyr2mLowDTql3KYY3ln6N62GHEkWMnkb98m3mhr1co5qs_ms_wCCboxNRKZtw2uJGqiKlzNDDnNdMPQuKon-SVq7RB0tZN7hxoO89yJS_23Fjpa5dpLANlrVC8-v_IbMOEFv622_hfP_5Wl |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRICYCLIC+COMPOUNDS+HAVING+CORTICOTROPIN-RELEASING+FACTOR+ANTAGONISTIC+ACTIVITY+AND+PHARMACEUTICAL+COMPOSITIONS+CONTAINING+THEM&rft.inventor=TAKAFUMI+TAKAI&rft.inventor=KATSUMI+KOBAYASHI&rft.inventor=YASUTAKA+HOASHI&rft.inventor=KAZUYOSHI+ASO&rft.inventor=MICHIYO+MOCHIZUKI&rft.inventor=KAZUYUKI+TOKUMARU&rft.inventor=TAKUTO+KOJIMA&rft.date=2010-08-10&rft.externalDBID=A&rft.externalDocID=MX2010008039A |